OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 44
Yen-Der Li, W Michelle, Muhammad Murtaza Hassan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
RIPTACs: A groundbreaking approach to drug discovery
Zonghui Ma, Andrew A. Bolinger, Jia Zhou
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103774-103774
Open Access | Times Cited: 9
Zonghui Ma, Andrew A. Bolinger, Jia Zhou
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103774-103774
Open Access | Times Cited: 9
Exploration of the Tunability of BRD4 Degradation by DCAF16Trans-labelling Covalent Glues
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders
Simon C. C. Lucas, Afshan Ahmed, Saba Ashraf, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5538-5566
Closed Access | Times Cited: 3
Simon C. C. Lucas, Afshan Ahmed, Saba Ashraf, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5538-5566
Closed Access | Times Cited: 3
Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library
Hlib Razumkov, Zixuan Jiang, Kheewoong Baek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Hlib Razumkov, Zixuan Jiang, Kheewoong Baek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Pooled endogenous protein tagging and recruitment for systematic profiling of protein function
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
Cell Genomics (2024), pp. 100651-100651
Open Access | Times Cited: 2
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
Cell Genomics (2024), pp. 100651-100651
Open Access | Times Cited: 2
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Yevgeniy V. Serebrenik, Deepak Mani, Timothé Maujean, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation
Surendra Kumar, Muthukumaran Venkatachalapathy, Ramesh Sistla, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104205-104205
Open Access | Times Cited: 1
Surendra Kumar, Muthukumaran Venkatachalapathy, Ramesh Sistla, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104205-104205
Open Access | Times Cited: 1
Molecular glue degrader for tumor treatment
Yuhan Hu, Yan Yan, Jiehao Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Yuhan Hu, Yan Yan, Jiehao Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders
Melissa Lim, Thang Do Cong, Lauren M. Orr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Melissa Lim, Thang Do Cong, Lauren M. Orr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1
DET1 dynamics underlie co-operative ubiquitination by CRL4DET1-COP1 complexes
Abigail E. Burgess, Tarren A. Loughran, Liam S. Turk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Abigail E. Burgess, Tarren A. Loughran, Liam S. Turk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
BRD4 as an emerging epigenetic therapeutic target for inflammatory bowel disease
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
A resource to enable chemical biology and drug discovery of WDR Proteins
Suzanne Ackloo, Fengling Li, Magda Szewczyk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Suzanne Ackloo, Fengling Li, Magda Szewczyk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Synthetic modification of protein surfaces to mediate induced-proximity pharmacology
Lyn H. Jones
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 2974-2979
Closed Access
Lyn H. Jones
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 9, pp. 2974-2979
Closed Access
Covalency in PROTACs: Mechanisms and applications
Thomas Geiger, Radosław P. Nowak
Annual reports in medicinal chemistry (2024), pp. 39-61
Closed Access
Thomas Geiger, Radosław P. Nowak
Annual reports in medicinal chemistry (2024), pp. 39-61
Closed Access
Covalency-enabled Drug Discovery is Redefining Druggability
Jeffrey M. McKenna, Rupert S. J. Proctor
CHIMIA International Journal for Chemistry (2023) Vol. 77, Iss. 7/8, pp. 537-537
Open Access | Times Cited: 1
Jeffrey M. McKenna, Rupert S. J. Proctor
CHIMIA International Journal for Chemistry (2023) Vol. 77, Iss. 7/8, pp. 537-537
Open Access | Times Cited: 1
Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches
Qi Miao, Vilas D. Kadam, Ayan Mukherjee, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13369-13383
Closed Access | Times Cited: 1
Qi Miao, Vilas D. Kadam, Ayan Mukherjee, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13369-13383
Closed Access | Times Cited: 1
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Ophir Shalem, Yevgeniy V. Serebrenik, Deepak Mani, et al.
Research Square (Research Square) (2023)
Open Access
Ophir Shalem, Yevgeniy V. Serebrenik, Deepak Mani, et al.
Research Square (Research Square) (2023)
Open Access
